Keisuke Ishikawa, Masayoshi Nagata, Yuta Anno, Miki Yamagishi, Toshiyuki China, Fumitaka Shimizu, Shuji Isotani, Satoru Muto, Shigeo Horie. Successful wound closure using fibrin glue for intractable neobladder-urethral anastomosis leakage after radical cystectomy and neobladder reconstruction. IJU case reports. 2023. 6. 5. 267-270
Shuji Isotani, Peter Ka-Fung Chiu, Takeshi Ashizawa, Yan-Ho Fung, Takeshi Ieda, Toshiyuki China, Haruna Kawano, Fumitaka Shimizu, Masayoshi Nagata, Yuki Nakagawa, et al. Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men. Prostate international. 2023. 11. 3. 180-185
Tomoki Kimura, Haruna Kawano, Satoru Muto, Nobuhito Muramoto, Toshiaki Takano, Yan Lu, Hidetaka Eguchi, Hiroo Wada, Yasushi Okazaki, Hisamitsu Ide, et al. PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease. Biomolecules. 2023. 13. 7. 1020-1020
Amiko Hino, Satoru Muto, Yosuke Shimada, Satoshi Hori, Shuji Isotani, Masayoshi Nagata, Shigeo Horie. Impact of cisplatin-induced acute kidney injury on long-term renal function in patients with solid tumors. Clinical and experimental nephrology. 2023. 27. 6. 506-518
Hisashi Hirano, Masayoshi Nagata, Naoya Nagaya, So Nakamura, Takeshi Ashizawa, Yan Lu, Haruna Kawano, Kosuke Kitamura, Yoshiro Sakamoto, Kazuhiko Fujita, et al. Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases. Scientific reports. 2023. 13. 1. 8704-8704
Focal HIFU is the Effective Alternative Treatment for Low-Risk Localized Prostate Cancer
(The 4th Congress of Asian Pacific Prostate Society(APPS) 2014)
The efficacy of EORTC risk tables in Japanese patients with non-muscle invasive bladder cancer.
(ASCO-GU 2014)